Drug intelligence / Profile preview

cbd-rich cannabis oil

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Sublingual, Topical, Inhalation, Transdermal
01

Overview

CBD-rich cannabis oil is an extract from the Cannabis sativa plant that contains high concentrations of cannabidiol (CBD) and low levels of tetrahydrocannabinol (THC). Unlike THC, CBD is not psychoactive and does not produce a "high." The primary mechanism of action involves modulation of the endocannabinoid system by interacting with cannabinoid receptors in the body, which are involved in regulating pain sensation, inflammation, mood, and other physiological processes. CBD-rich oils are used for a variety of potential therapeutic purposes including seizure disorders (notably Dravet syndrome and Lennox-Gastaut syndrome), chronic pain management, anxiety reduction, anti-inflammatory effects, sleep disorders such as insomnia, and as adjunctive therapy for certain neurological conditions. The only FDA-approved prescription form of pure CBD is Epidiolex for specific types of epilepsy; however, over-the-counter CBD oils are widely available but lack regulatory approval for medical indications[1][2][4][5][8].

Other names
cannabidiol-rich cannabis oilCBD oilcannabidiol oil
02

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on cbd-rich cannabis oil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cbd-rich cannabis oil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call